Citation Impact
Citing Papers
MASP-1, a Promiscuous Complement Protease: Structure of Its Catalytic Region Reveals the Basis of Its Broad Specificity
2009
Parenteral Anticoagulants
2012 Standout
Heparin-Protein Interactions
2002 Standout
Serine 380 (P14) → Glutamate Mutation Activates Antithrombin as an Inhibitor of Factor Xa
2000
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Importance of the P2 Glycine of Antithrombin in Target Proteinase Specificity, Heparin Activation, and the Efficiency of Proteinase Trapping as Revealed by a P2 Gly → Pro Mutation
1999
Lysine Residue 114 in Human Antithrombin III Is Required for Heparin Pentasaccharide-mediated Activation
1997
The Pharmacokinetics of Fondaparinux Sodium in Healthy Volunteers
2002
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
2010
Wearable biosensors for healthcare monitoring
2019 Standout
Role of the Catalytic Serine in the Interactions of Serine Proteinases with Protein Inhibitors of the Serpin Family
1995
Mechanism of Heparin Activation of Antithrombin
1998
Critical Role of the Linker Region between Helix D and Strand 2A in Heparin Activation of Antithrombin
2000
Calcium Enhances Heparin Catalysis of the Antithrombin-Factor Xa Reaction by a Template Mechanism
1998
Chronic performance of polyurethane catheters covalently coated with ATH complex: A rabbit jugular vein model
2006
NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata
1994 StandoutNobel
Perioperative Management of Antithrombotic Therapy
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle>
2002
Probing the Coagulation Pathway with Aptamers Identifies Combinations that Synergistically Inhibit Blood Clot Formation
2014
Control of granzymes by serpins
2009
Surface Expression and Ligand-Based Selection of cDNAs Fused to Filamentous Phage Gene VI
1995
Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities
2014 StandoutNobel
Requirement of Lysine Residues Outside of the Proposed Pentasaccharide Binding Region for High Affinity Heparin Binding and Activation of Human Antithrombin III
1996
Saliva as a diagnostic fluid
2002
The pH Dependence of Serpin-Proteinase Complex Dissociation Reveals a Mechanism of Complex Stabilization Involving Inactive and Active Conformational States of the Proteinase Which Are Perturbable by Calcium
2001
Implications for function and therapy of a 2.9 å structure of binary-complexed antithrombin
1998
Kinetic Characterization of the Proteinase Binding Defect in a Reactive Site Variant of the Serpin, Antithrombin
1995
Genome sequence of the endocellular bacterial symbiont of aphids Buchnera sp. APS
2000 StandoutNature
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Metagenomic biomarker discovery and explanation
2011 Standout
Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide
1992
Heparin Enhances the Specificity of Antithrombin for Thrombin and Factor Xa Independent of the Reactive Center Loop Sequence
2001
Aptamers as therapeutics
2010 Standout
Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases
2016 StandoutNobel
Helix D Elongation and Allosteric Activation of Antithrombin
2002
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
The Antiphospholipid Syndrome
2002 Standout
Lysine-Heparin Interactions in Antithrombin. Properties of K125M and K290M,K294M,K297M Variants
1994
Role of Arginine 129 in Heparin Binding and Activation of Antithrombin
2000
Lysine 114 of Antithrombin Is of Crucial Importance for the Affinity and Kinetics of Heparin Pentasaccharide Binding
2001
GLYCAM06: A generalizable biomolecular force field. Carbohydrates
2007 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Prevention of Venous Thromboembolism
2004 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Heparan Sulfate Targets the HIV-1 Envelope Glycoprotein gp120 Coreceptor Binding Site
2005
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
The COG database: a tool for genome-scale analysis of protein functions and evolution
2000 Standout
Prevention of Venous Thromboembolism
2008 Standout
New anticoagulants: how to deal with treatment failure and bleeding complications
2011
Fondaparinux Sodium Mechanism of Action
2002
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Periodontal diseases
2005 Standout
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo
1998 StandoutNobel
Surface Display of Proteins on Bacteriophage λ Heads
1996 StandoutNobel
On the mechanisms of biocompatibility
2008 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Interaction of factor Xa with heparin does not contribute to the inhibition of factor Xa by antithrombin III-heparin
1990
Role of Arginine 132 and Lysine 133 in Heparin Binding to and Activation of Antithrombin
1996
Application of microchip assay system for the measurement of C-reactive protein in human saliva
2005
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm
2006 Standout
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites
1992
Crystallographic publishing in the electronic age
2007
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Glycosaminoglycans and the regulation of blood coagulation
1993
The anticoagulant activation of antithrombin by heparin
1997
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Phosphorothioate Oligonucleotides Inhibit the Intrinsic Tenase Complex
1998
Mechanism of Acceleration of Antithrombin-Proteinase Reactions by Low Affinity Heparin
1995
Peptide Antimicrobial Agents
2006 Standout
gp340 Promotes Transcytosis of Human Immunodeficiency Virus Type 1 in Genital Tract-Derived Cell Lines and Primary Endocervical Tissue
2009 StandoutNobel
Serpin Structure, Mechanism, and Function
2002 Standout
Functions of the gene products of Escherichia coli
1993
HIV Envelope Binding by Macrophage-Expressed gp340 Promotes HIV-1 Infection
2008 StandoutNobel
Energetics and Dynamics of Enzymatic Reactions
2001 StandoutNobel
Absence of Placental Transfer of Pentasaccharide (Fondaparinux, Arixtra®) in the Dually Perfused Human Cotyledon in vitro
2002
The Primary Structure of Escherichia coli L-Threonine Dehydrogenase
1989
The clinical value of salivary biomarkers for periodontal disease
2009
Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-II
1990 StandoutNatureNobel
Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans
1994
Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa.
1995
Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
2002
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
1990
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
1999 Standout
Biological implications of a 3 å structure of dimeric antithrombin
1994
Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases
2008
Biochemical and Pharmacological Properties of SANORG 34006, a Potent and Long-Acting Synthetic Pentasaccharide
1998
The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics
1993
Defining an Antigenic Epitope on Platelet Factor 4 Associated With Heparin-Induced Thrombocytopenia
1998
Kinetic characterization of the substrate reaction between a complex of antithrombin with a synthetic reactive-bond loop tetradecapeptide and four target proteinases of the inhibitor.
1992
Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects.
1991
publCIF: software for editing, validating and formatting crystallographic information files
2010 Standout
Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]
1993
A Simple Saliva-Based Test for Detecting Antibodies to Human Immunodeficiency Virus
1999
Low-Molecular-Weight Heparins
1997 Standout
Die charakteristische AT‐III‐Bindungsregion in Heparin: eine Leitstruktur für neue synthetische Antithrombotica
1993
The Complete Genome Sequence of Escherichia coli K-12
1997 StandoutScience
Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin
1994
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
A Genomic Perspective on Protein Families
1997 StandoutScience
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel
Detection of Human Immunodeficiency Virus Antibodies in Oral Fluids
1998
Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles
1991
Works of P. Craig being referenced
Drugs of Abuse in Saliva: A Review
1992
The sulfhydryl content of l-threonine dehydrogenase from Escherichia coli K-12: relation to catalytic activity and Mn2+ activation
1990
Isolation of human blood coagulation α-factor Xa by soybean trypsin inhibitor-Sepharose chromatography and its active-site titration with fluorescein mono-p-guanidinobenzoate
1989
Methods of Simplified Saliva Collection for the Measurement of Drugs of Abuse, Therapeutic Drugs, and Other Molecules
1993
Kinetics of Heparin Actiona
1989
BioEditor—simplifying macromolecular structure annotation
2003
Testosterone concentration is increased in whole saliva, but not in ultrafiltrate, after toothbrushing
1993
Determination of free progesterone in an ultrafiltrate of saliva collected in situ
1990
L-Threonine dehydrogenase from Escherichia coli K-12: thiol-dependent activation by manganese(2+)
1986
Cocaine and benzoylecgonine in saliva, serum, and urine
1993
Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
1992
Transient Kinetics of Heparin-catalyzed Protease Inactivation by Antithrombin III
1989